Prime Capital Investment Advisors, LLC Genprex, Inc. Transaction History

Prime Capital Investment Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 06, 2020	SELL	$2.9 - $4.29 $2,900 - $4,290	-1,000 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$1.99 - $3.64 $1,990 - $3,640	1,000 New	1,000 $3,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $48.5M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.